financetom
Business
financetom
/
Business
/
Rocket Lab USA Insider Sold Shares Worth $1,277,475, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rocket Lab USA Insider Sold Shares Worth $1,277,475, According to a Recent SEC Filing
Nov 29, 2024 1:06 AM

03:33 AM EST, 11/29/2024 (MT Newswires) -- Merline Saintil, Director, on November 26, 2024, sold 50,000 shares in Rocket Lab USA ( RKLB ) for $1,277,475. Following the Form 4 filing with the SEC, Saintil has control over a total of 432,275 shares of the company, with 432,275 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819994/000095017024131622/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hyundai Steel actively considering building US plant
Hyundai Steel actively considering building US plant
Jan 22, 2025
SEOUL, Jan 22 (Reuters) - South Korea's Hyundai Steel , an affiliate of automakers Hyundai Motor ( HYMTF ) and Kia, said on Wednesday it is actively considering building a steel plant in the United States. The move comes at a time when U.S. President Donald Trump is expected to step up protectionist trade policies, including potentially imposing 25% tariffs...
C3.ai Partners With McKinsey to Accelerate Enterprise AI Transformations
C3.ai Partners With McKinsey to Accelerate Enterprise AI Transformations
Jan 22, 2025
03:54 AM EST, 01/22/2025 (MT Newswires) -- C3.ai ( AI ) said late Tuesday it partnered with McKinsey & Company to help clients across industries speed up their Enterprise AI transformations. The company said the partnership combines McKinsey's AI expertise through its QuantumBlack unit with C3.ai's ( AI ) advanced Enterprise AI software to drive operational improvements. It added that...
ArriVent BioPharma Enters Licensing Deal With Lepu Biopharma for Gastrointestinal Cancer Drug
ArriVent BioPharma Enters Licensing Deal With Lepu Biopharma for Gastrointestinal Cancer Drug
Jan 22, 2025
03:46 AM EST, 01/22/2025 (MT Newswires) -- ArriVent BioPharma ( AVBP ) said late Tuesday it has entered into an exclusive licensing agreement with Lepu Biopharma to develop and commercialize gastrointestinal cancer drug MRG007 outside of Greater China. Under the terms of the deal, Lepu Biopharma will get an upfront payment and near-term milestone payments totaling $47 million in cash...
Sabadell's board meets to discuss transferring HQ back to Catalonia
Sabadell's board meets to discuss transferring HQ back to Catalonia
Jan 22, 2025
By Jesús Aguado MADRID (Reuters) - Spain's Banco Sabadell plans to hold an extraordinary board meeting on Wednesday to discuss the transfer of its headquarters back to Catalonia from Alicante, the bank said in a statement to the stock market supervisor. On Tuesday, two sources with knowledge of the matter said the board would propose moving its headquarters back to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved